PTC Therapeutics Inc
PTCT
Market Cap$3.85B
Close$
$29.89
42.2% downside
Current Fair Value
42.2% downsideOvervalued by 42.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.85 Billion |
|---|---|
| Enterprise Value | $2.83 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.73 |
| Beta | 0.52 |
| Outstanding Shares | 78,115,836 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 6.37 |
|---|---|
| PEG | -0.61 |
| Price to Sales | 2.46 |
| Price to Book Ratio | -17.24 |
| Enterprise Value to Revenue | 1.66 |
| Enterprise Value to EBIT | 3.48 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | -2.51 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About PTC Therapeutics Inc
CEO: Stuart Peltz